ETON
Eton Pharmaceuticals Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
eton pharmaceuticals, inc. is a deer park, illinois-based pharmaceutical company focused on developing and commercializing innovative pharmaceutical products utilizing the u.s. food and drug administration’s 505(b)(2) regulatory pathway. our mission is to advance healthcare through the introduction of innovative medicines that are affordable and available to all patients.
Market Cap: 111 Million
Primary Exchange: NASDAQ
Website: etonpharma.com
Shares Outstanding: 25.7 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.5011354585338338
Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
Ethical Flags
Longest drawdown: 996 trading days
From: 2021-02-17 To: 2024-03-07
Lowest Point:
Eton Pharma in-licenses epilepsy candidate from Aucta Pharma
via: SeekingAlpha at 2019-06-13 12:14:17:000
Eton Pharmaceuticals (NASDAQ: ETON ) inks an agreement with Aucta Pharmaceuticals for U.S. rights to ET-105, an oral liquid formulation of lamotrigine for the adjunctive treatment of partial seizures in epilepsy patients. More news on: Eton Pharmaceuticals, Inc., Healthcare stocks news, … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|